Globe Newswire (Tue, 13-Oct 9:00 AM ET)
Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders?
PRNewswire (Mon, 12-Oct 8:50 PM ET)
OPCH Investors Have Opportunity to Join Option Care Health, Inc. Fraud Investigation with SBS Law
Business Wire (Mon, 12-Oct 3:59 PM ET)
Option Care Health (OPCH) was downgraded to a Hold Rating at J.P. Morgan
TipRanks (Mon, 12-Oct 5:17 AM ET)
PRNewswire (Sun, 11-Oct 12:35 PM ET)
Key deals this week: Option Care Health, PTC, Energy Transfer and more
Seeking Alpha News (Sat, 10-Oct 3:15 PM ET)
Business Wire (Thu, 8-Oct 4:34 PM ET)
Globe Newswire (Tue, 6-Oct 11:03 PM ET)
OPCH SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES OPTION CARE HEALTH, INC.
PRNewswire (Tue, 6-Oct 9:45 PM ET)
Business Wire (Tue, 6-Oct 11:24 AM ET)
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.
Option Care Health trades on the NASDAQ stock market under the symbol OPCH.
As of October 14, 2026, OPCH stock price climbed to $31.12 with 4,557,185 million shares trading.
OPCH has a beta of 0.57, meaning it tends to be less sensitive to market movements. OPCH has a correlation of 0.02 to the broad based SPY ETF.
OPCH has a market cap of $4.66 billion. This is considered a Mid Cap stock.
Last quarter Option Care Health reported $1 billion in Revenue and $.45 earnings per share. This beat revenue expectation by $23 million and exceeded earnings estimates by $.03.
In the last 3 years, OPCH traded as high as $36.80 and as low as $18.01.
The top ETF exchange traded funds that OPCH belongs to (by Net Assets): IJH, IWM, VTI, VB, DFAT.
OPCH has underperformed the market in the last year with a return of +16.7%, while SPY returned +17.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in OPCH shares. However, OPCH has outperformed the market in the last 3 month and 2 week periods, returning +43.4% and +36.4%, while SPY returned +3.0% and +0.7%, respectively. This indicates OPCH has been having a stronger performance recently.
OPCH support price is $30.44 and resistance is $31.76 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OPCH shares will trade within this expected range on the day.
